Industry News - Tag: COVID-19

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Regulatory in brief / CBD, Norway, COVID-19

23 December 2020

The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...

Read the full story

GSCF intends to build on greater self-care recognition

17 November 2020

Promoting the self-care industry as a true contributor to a healthier world is the most important objective for the Global Self-Care Federation (GSCF), says Bayer Consumer Health’s Heiko Schipper, who has just been elected chair of the federation. Sustainability is also an important issue, Schipper...

Read the full story

Strong VMS sales continue to lift Bayer
Premium

9 November 2020

Bayer Consumer Health’s portfolio of vitamins, minerals and supplements (VMS) continued to record strong sales growth in the third quarter of 2020, but sales of the company’s Allergy & Cold products continued to decline.

Read the full story

Perrigo highlights “sticky” COVID-19 trends
Premium

6 November 2020

The COVID-19 pandemic has led to a “meaningful and accelerated” purchasing shift from branded to store-brand products, according to Murray Kessler, Perrigo’s president and chief executive officer, as well as a channel shift from brick-and-mortar to e-commerce.

Read the full story

GSK highlights e-commerce gains during 2020
Premium

2 November 2020

GlaxoSmithKline (GSK) Consumer Healthcare’s e-commerce sales increased by about 80% in the first nine months of 2020, according to chief executive officer Brian McNamara, who said the business had grown “significantly ahead of the market” in e-commerce and was “gaining share”.

Read the full story